|
![]() |
|||
|
||||
OverviewDiabetes has reached epidemic proportions, and the cardiovascular complications of diabetes are life-threatening and disabling. This book is unique in providing a simple explanation of the biochemical role of PKC in diabetes complications, which allows clinicians to understand why PKC inhibitors (in development) are an exciting prospect for future treatment to slow progression of eye and foot complications. This book is updated throughout to reflect the impact of recent major clinical trials on current clinical practice. It includes a major new section on diabetic neuropathy and a revised section on diabetic retinopathy. Each chapter is short and succinct, focusing on 'best practice'. There are key learning points at the end of each chapter, with numerous helpful tables, figures and clinical images. Full Product DetailsAuthor: Richard Donnelly , Edward HortonPublisher: John Wiley & Sons Imprint: John Wiley & Sons ISBN: 9786611322373ISBN 10: 661132237 Pages: 240 Publication Date: 01 January 2005 Audience: General/trade , General Format: Electronic book text Publisher's Status: Unknown Availability: Out of stock ![]() Table of ContentsReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |